DHA Supplementation and Pregnancy Outcome

Completed · Phase 3 · Has a placebo group

Conditions studied: Pregnancy

In brief

The purpose of the study is to determine if increasing DHA intake during pregnancy can increase gestation duration and enhance infant and childhood outcomes related to visual acuity, stereoacuity, attention, and distractibility.

Key facts

Study ID

NCT00266825

Run by

Susan Carlson, PhD

People needed

350

Starts

2006-01-01

Expected to finish

2011-10-01

Last updated by the study team

2016-03-14

Who can join

Age: 16 and older, up to 36. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Pregnant 8-20 wks at enrollment
• single fetus
• BMI <40

You may not qualify if…

• diabetes (Type I, ii, GDM)
• hypertension (primary, PIH, preeclampsia/eclampsia)

Where it is running

• University of Kansas Medical Center — Kansas City, Kansas, United States
• Truman Medical Center — Kansas City, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.